0001493152-15-006455.txt : 20151229 0001493152-15-006455.hdr.sgml : 20151229 20151229172506 ACCESSION NUMBER: 0001493152-15-006455 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151202 FILED AS OF DATE: 20151229 DATE AS OF CHANGE: 20151229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences Inc CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gormally John J CENTRAL INDEX KEY: 0001661118 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 151311884 MAIL ADDRESS: STREET 1: 80 WALSH DRIVE CITY: MAHWAH STATE: NJ ZIP: 07430 3 1 form3.xml X0206 3 2015-12-02 1 0001321834 Akers Biosciences Inc AKER 0001661118 Gormally John J 80 WALSH DRIVE MAHWAH NJ 07430 0 1 0 0 Chief Executive Officer Akers Biosciences, Inc. (the "Company") approved the appointment John J. Gormally as Chief Executive Officer of the Company, subject to the terms of conditions of an executed employment agreement. On December 2, 2015, the Company and Mr. Gormally finalized the terms of his employment and entered into an employment agreement (the "Employment Agreement"), pursuant to which Mr. Gormally will serve as the Company's Chief Executive Officer. /s/ John J. Gormally 2015-12-29